Pharmaceutical News

RSS

Clyde Biosciences announces £2 million ‘Series A’ investment

Clyde Biosciences Ltd. has announced a £2 million ‘Series A’ investment led by Epidarex Capital, a leading international early-stage life science venture capital fund.

15 Apr 2015

Clyde Biosciences, a leading drug toxicity testing company, closes Series A investment

Clyde Biosciences Ltd. (Clyde Biosciences) has announced a £2 million ‘Series A’ investment led by Epidarex Capital, a leading international early-stage life science venture capital fund. Scottish Enterprise’s investment arm, the Scottish Investment Bank, also participated in the round along with Glasgow University Holdings, Ltd.

14 Apr 2015

Sanofi introduces new probiotic supplement for children in South Korea

Sanofi launches a new probiotic supplement for kids in South Korea. Released, in Costco stores under the global Cenovis Kids brand, the new supplement with a delicious vanilla flavor and teddy bear shape is produced by Anlit Ltd., Israel, and designed specifically for kids.

14 Apr 2015

Humabs BioMed reports clinical milestone in medImmune partnership

Humabs BioMed SA, a leading Swiss antibody therapeutics company, today announced that a novel antibody developed through its proprietary Cellclone technology will be investigated for the treatment of influenza A...

14 Apr 2015

Amway named Company of the Year by IFANCA for halal-certified Nutrilite products

The Islamic Food and Nutrition Council of America named Amway as Company of the Year during the 2015 International Halal Food Conference for excellence in compliance and execution of halal-certified Nutrilite products in markets around the world.

13 Apr 2015

Studies reveal that dietary supplement can improve reproductive health

Current statistics on U.S. birth rates from the Centers for Disease Control and Prevention report a continued trend toward delayed motherhood. As fertility gradually declines in the 30s, particularly after age 35, the risk of experiencing difficulty conceiving may increase. In addition to age, there are other common reasons why women may experience difficulties conceiving, including: irregular ovulation cycles and poor egg quality, which may be associated with stress, lifestyle or poor diet.

13 Apr 2015

Penn researchers receive 2015 Vaccine Industry Excellence Award

The laboratory of David Weiner, PhD, a professor of Pathology and Laboratory Medicine at the Perelman School of Medicine at the University of Pennsylvania, received the 2015 Vaccine Industry Excellence Award for Best Academic Research Team, at the World Vaccine Congress in Washington, DC this week.

12 Apr 2015

Study explores the impact of costly hepatitis C drugs on Rhode Island's prison system

A new study finds that effective new hepatitis C drugs are so expensive the state of Rhode Island would have to spend almost twice its entire prison health budget to treat all its chronically infected inmates.

10 Apr 2015

Newly approved drug for rare blood cancer shows sustained benefit for 2 years

The most recent results from a clinical trial show that ibrutinib, a newly approved drug for Waldenstrom's Macroglobulinemia, continued to control the rare blood cancer, with 95 percent of patients surviving for two years, report investigators from Dana-Farber Cancer Institute.

10 Apr 2015

Stroke patients can benefit from clot-busting drug, shows brain scan study

A drug that breaks up blood clots in the brains of stroke patients could be used more widely than at present without increased risk, a brain scan study suggests.

10 Apr 2015

Fewer patients take effective gout drug after steep price increase

Study finds that fewer patients with gout received useful colchicine drug after FDA actions led to 50x increase in price.

10 Apr 2015

UofL-led study focuses on flu vaccine for children with neurological disorders

Children who have neurological disorders such as cerebral palsy or epilepsy are no more likely to be vaccinated against influenza than youngsters without these conditions, despite the increased risk for complications from flu these children experience.

10 Apr 2015

Amniotic stem cells promote growth of functional blood vessels in healing hydrogels

Rice University and Texas Children's Hospital scientists are using stem cells from amniotic fluid to promote the growth of robust, functional blood vessels in healing hydrogels.

10 Apr 2015

Impact Beverage launches breakthrough athletic supplement in Southern California

Impact Beverage LLC today announced the introduction of its breakthrough athletic supplement HeadOn to Southern California. The ready-to-drink formula, which launched in Colorado earlier this year, changes the way athletes and active individuals approach strenuous activity.

9 Apr 2015

UQDI reveals that Anisina drug can kill melanoma cells

US-Australian drug discovery company, Novogen, today announced that studies conducted at The University of Queensland Diamantina Institute revealed that experimental drug, Anisina, killed melanoma cells irrespective of their mutational status.

9 Apr 2015

Study: Viagra, other related drugs not a universal 'cure-all' for impotence

Viagra and other related drugs are not a universal 'cure-all' for impotence, according to a new study from The University of Manchester and NatCen Social Research.

9 Apr 2015

Vanderbilt researchers join multi-center effort to accelerate development of potential Ebola therapy

Vanderbilt University researchers have joined a multi-center effort led by Pennsylvania-based Inovio Pharmaceuticals Inc. to accelerate development of potential antibody therapies against the often-lethal Ebola virus.

9 Apr 2015

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the selection of RG-125 (AZD4076), a GalNAc-conjugated anti-miR targeting microRNA-103/107 (“miR-103/107”) for the treatment of Non Alcoholic Steatohepatitis (“NASH) in patients with type 2 diabetes/pre-diabetes, as a clinical candidate by AstraZeneca under the companies’ strategic alliance to discover, develop and commercialize microRNA therapeutics.

9 Apr 2015

UTMB scientists develop quick-acting vaccine that is effective against Ebola strain

An interdisciplinary team from The University of Texas Medical Branch at Galveston and Profectus BioSciences, Inc. has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year.

8 Apr 2015

Uninsured cancer patients may face higher charges for chemotherapy drugs

Uninsured cancer patients are asked to pay anywhere from two to 43 times what Medicare would pay for chemotherapy drugs, according to a new study from the University of North Carolina at Chapel Hill.

8 Apr 2015

Pharmaceutical News

Clyde Biosciences announces £2 million ‘Series A’ investment

Clyde Biosciences, a leading drug toxicity testing company, closes Series A investment

Sanofi introduces new probiotic supplement for children in South Korea

Humabs BioMed reports clinical milestone in medImmune partnership

Amway named Company of the Year by IFANCA for halal-certified Nutrilite products

Studies reveal that dietary supplement can improve reproductive health

Penn researchers receive 2015 Vaccine Industry Excellence Award

Study explores the impact of costly hepatitis C drugs on Rhode Island's prison system

Newly approved drug for rare blood cancer shows sustained benefit for 2 years

Stroke patients can benefit from clot-busting drug, shows brain scan study

Fewer patients take effective gout drug after steep price increase

UofL-led study focuses on flu vaccine for children with neurological disorders

Amniotic stem cells promote growth of functional blood vessels in healing hydrogels

Impact Beverage launches breakthrough athletic supplement in Southern California

UQDI reveals that Anisina drug can kill melanoma cells

Study: Viagra, other related drugs not a universal 'cure-all' for impotence

Vanderbilt researchers join multi-center effort to accelerate development of potential Ebola therapy

AstraZeneca selects Regulus' RG-125 as clinical candidate for treatment of NASH

UTMB scientists develop quick-acting vaccine that is effective against Ebola strain

Uninsured cancer patients may face higher charges for chemotherapy drugs

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News